These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 806645)

  • 1. Site of inhibitory action of isoniazid in the synthesis of mycolic acids in Mycobacterium tuberculosis.
    Takayama K; Schnoes HK; Armstrong EL; Boyle RW
    J Lipid Res; 1975 Jul; 16(4):308-17. PubMed ID: 806645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of mycolate synthetase activity in Mycobacterium tuberculosis exposed to isoniazid.
    Takayama K; Armstrong EL; David HL
    Am Rev Respir Dis; 1974 Jul; 110(1):43-8. PubMed ID: 4209359
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis.
    Takayama K; Wang L; David HL
    Antimicrob Agents Chemother; 1972 Jul; 2(1):29-35. PubMed ID: 4208567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of low temperature on growth, viability, and synthesis of mycolic acids of Mycobacterium tuberculosis strain H37Ra.
    Takayama K; Armstrong EL; Davidson LA; Kunugi KA; Kilburn JO
    Am Rev Respir Dis; 1978 Jul; 118(1):113-7. PubMed ID: 98081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the uptake of isoniazid and its action on in vivo mycolic acid synthesis in Mycobacterium tuberculosis.
    Wang L; Takayama K
    Antimicrob Agents Chemother; 1972 Dec; 2(6):438-41. PubMed ID: 4207759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation, characterization, and function of 6-mycolyl-6'-acetyltrehalose in the H37Ra strain of Myocobacterium tuberculosis.
    Takayama K; Armstrong EL
    Biochemistry; 1976 Jan; 15(2):441-7. PubMed ID: 813763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoniazid inhibition of the synthesis of monounsaturated long-chain fatty acids in Mycobacterium tuberculosis H37Ra.
    Davidson LA; Takayama K
    Antimicrob Agents Chemother; 1979 Jul; 16(1):104-5. PubMed ID: 112917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosynthesis of C30 to C56 fatty acids by an extract of Mycobacterium tuberculosis H37Ra.
    Qureshi N; Sathyamoorthy N; Takayama K
    J Bacteriol; 1984 Jan; 157(1):46-52. PubMed ID: 6418722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis.
    Schroeder EK; de Souza N; Santos DS; Blanchard JS; Basso LA
    Curr Pharm Biotechnol; 2002 Sep; 3(3):197-225. PubMed ID: 12164478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isonicotinic acid hydrazide induced changes and inhibition in mycolic acid synthesis in Nocardia and related taxa.
    Tomiyasu I; Yano I
    Arch Microbiol; 1984 Apr; 137(4):316-23. PubMed ID: 6428369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of isoniazid on ultrastructure of Mycobacterium aurum and Mycobacterium tuberculosis and on production of secreted proteins.
    Bardou F; Quémard A; Dupont MA; Horn C; Marchal G; Daffé M
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2459-67. PubMed ID: 8913447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Effect of DFC-2 on Mycolic Acid Biosynthesis in
    Kim S; Seo H; Mahmud HA; Islam MI; Kim YS; Lyu J; Nam KW; Lee BE; Lee KI; Song HY
    J Microbiol Biotechnol; 2017 Nov; 27(11):1932-1941. PubMed ID: 28870005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IQG-607 abrogates the synthesis of mycolic acids and displays intracellular activity against Mycobacterium tuberculosis in infected macrophages.
    Rodrigues-Junior VS; dos Santos Junior AA; Villela AD; Belardinelli JM; Morbidoni HR; Basso LA; Campos MM; Santos DS
    Int J Antimicrob Agents; 2014 Jan; 43(1):82-5. PubMed ID: 24139881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective action of isoniazid on the synthesis of cell wall mycolates in mycobacteria.
    Takayama K
    Ann N Y Acad Sci; 1974 May; 235(0):426-38. PubMed ID: 4212333
    [No Abstract]   [Full Text] [Related]  

  • 15. Determination of the primary target for isoniazid in mycobacterial mycolic acid biosynthesis with Mycobacterium aurum A+.
    Wheeler PR; Anderson PM
    Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):451-7. PubMed ID: 8809032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethylenic mycolic acid biosynthesis: extension of the biosynthetic model using cell-free extracts of Mycobacterium aurum and Mycobacterium smegmatis.
    Lopez-Marin LM; Quemard A; Laneelle G; Lacave C
    Biochim Biophys Acta; 1991 Oct; 1086(1):22-8. PubMed ID: 1954242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of C22-, C24- and C26-alpha-unit-containing mycolic acid homologues in mycobacteria.
    Kaneda K; Imaizumi S; Yano I
    Microbiol Immunol; 1995; 39(8):563-70. PubMed ID: 7494494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of isoniazid on mycolic acid synthesis in Mycobacterium tuberculosis and on its cell envelope.
    Winder FG; Collins P; Rooney SA
    Biochem J; 1970 Apr; 117(2):27P. PubMed ID: 4986870
    [No Abstract]   [Full Text] [Related]  

  • 19. The methyl-branched fortifications of Mycobacterium tuberculosis.
    Minnikin DE; Kremer L; Dover LG; Besra GS
    Chem Biol; 2002 May; 9(5):545-53. PubMed ID: 12031661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of KasA and KasB in the biosynthesis of meromycolic acids and isoniazid resistance in Mycobacterium tuberculosis.
    Slayden RA; Barry CE
    Tuberculosis (Edinb); 2002; 82(4-5):149-60. PubMed ID: 12464486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.